Biotech Startups
10,002 companies tagged Biotech, with their investors and founders.
0 investors
0 investors
0 investors
Diagnostic Biochips develops multichannel neural probes for extracellular recording in electrophysiology research, along with cloud-based software for spike sorting and analysis. It serves neuroscience researchers studying the brain at the neural network level.
0 investors
Dialectic Therapeutics is a clinical-stage biotechnology company developing anti-cancer drugs using its Antiapoptotic Protein Targeted Degradation (APTaD) platform, which induces cancer cells to degrade proteins such as BCL-XL. Its lead candidate, DT2216, is in Phase 1/2 trials for fibrolamellar carcinoma and platinum-resistant ovarian cancer.
0 investors
DiaMedica Therapeutics develops therapies aimed at reducing ischemia in patients with serious vascular diseases, with an initial focus on preeclampsia, fetal growth restriction, and acute ischemic stroke. It is a clinical-stage biopharmaceutical company working on treatments for ischemic disorders.
0 investors
Equipment and manufacturing technology company providing continuous processing systems for lipid nanoparticles and other pharmaceutical nanoparticles.
0 investors
0 investors
0 investors
Diceros Therapeutics develops Verasone, a drug candidate combining two existing therapies for treatment of chronic rhinosinusitis via sinonasal irrigation. The company is advancing the treatment through clinical trials to provide improved efficacy and reduced side effects compared to existing options.
0 investors
0 investors
0 investors
0 investors
Dilon Technologies is a medical device manufacturer that develops surgical instruments and diagnostic tools for healthcare practitioners, including gamma probes for lymphatic mapping, margin assessment devices for breast cancer surgery, and video laryngoscopes.
0 investors
Dimer Instruments develops high-performance scientific instruments for biopharmaceutical analysis, using light scattering and biophysical characterization technologies to accelerate drug development processes. The company serves pharmaceutical researchers and drug development teams.
0 investors
0 investors
0 investors
0 investors
Diverse Biotech develops novel synthetic cannabinoid compounds and drug conjugate therapies aimed at cancer treatment. The company operates in the pharmaceutical and biotech sector with a focus on oncology therapeutics.
0 investors
0 investors
0 investors
0 investors
0 investors
0 investors